CEN Biotech Earnings Estimate
CEN Biotech Earnings per Share Projection vs Actual
About CEN Biotech Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of CEN Biotech earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current CEN Biotech estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as CEN Biotech fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.CEN Biotech, Inc. focuses on the manufacture, production, and development of light emitting diode lighting technology and hemp-based products. The company was incorporated in 2013 and is based in Windsor, Canada. Cen Biotech operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Currently Active Assets on Macroaxis
Other Information on Investing in CEN Pink Sheet
CEN Biotech financial ratios help investors to determine whether CEN Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CEN with respect to the benefits of owning CEN Biotech security.